Observational study finds higher basal ganglia perivascular space burdens increase ischemic and bleeding risks in patients on antithrombotic therapy, suggesting personalized assessments.
Higher BGPVS burdens are associated with higher risks of ischemic stroke and major bleeding in patients receiving antithrombotic therapy. BGPVSs may serve as useful imaging biomarkers for vascular risk assessment and personalized therapy.
No takes yet. Share an insight, caveat, or question.
Iwamoto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: